Advertisement

Topics

Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea

2010-07-15 17:00:00 | BioPortfolio

Summary

The purpose of this study is to determine whether NPC-01 is effective in the treatment of dysmenorrhea.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Conditions

Dysmenorrhea

Intervention

NPC-01

Status

Not yet recruiting

Source

Nobelpharma

Results (where available)

View Results

Links

Published on BioPortfolio: 2010-07-15T17:00:00-0400

Clinical Trials [56 Associated Clinical Trials listed on BioPortfolio]

Randomized Controlled Trial of Acupuncture for Dysmenorrhea

Since there is unsatisfactory effect by currently pharmacologic therapies and preventive strategies for dysmenorrhea, this study is designed to evaluate the efficacy and quality of life of...

Pulse Diagnoses in Patients While Dysmenorrhea is Attacking

The mechanism led to the dysmenorrhea can be understood more clearly and one may have a better idea to treat the disease in the future.

The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea

Dysmenorrhea (painful menstruation) is a common gynaecological disorder that is prevalent in more than 50% of women during their reproductive years. Primary dysmenorrhea describes cyclic u...

A Study to Evaluate the Effect of Vaginal Rings on Primary Dysmenorrhea (P08257/MK-8175A/MK-8342B-057)

The study investigates four vaginal ring groups with respect to relief of primary dysmenorrhea, and should identify at least one vaginal ring that shows clinically relevant treatment effic...

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea

The purpose of this study is to evaluate the pain relieving effect and safety of an investigational drug in women with moderate to severe primary dysmenorrhea (painful menstruation).

PubMed Articles [22 Associated PubMed Articles listed on BioPortfolio]

Somatic symptoms in women with dysmenorrhea and noncyclic pelvic pain.

Somatic symptoms are a robust, transdiagnostic risk factor for pain conditions. However, the extent to which somatic symptoms contribute to the manifestation of the women's pain syndromes, such as dys...

Analysis of characteristics and influence factors of diagnostic delay of endometriosis.

To access the influence factors of diagnostic delay of endometriosis.We designed a questionnaire of diagnostic delay of endometriosis. From February 2014 to February 2016, 400 patients who had dysmeno...

Physical activity for primary dysmenorrhea: a systematic review and meta-analysis of randomized controlled trials.

Primary dysmenorrhea is cramping abdominal pain associated with menses. It is prevalent, affects quality of life, and can cause absenteeism. Although evidence based medical treatment options exist, wo...

Association of primary dysmenorrhea with anthropometrical and socio-economic factors in Polish university students.

To examine the prevalence and factors correlated with primary dysmenorrhea in young female subjects.

High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents.

Vitamin D has a crucial role in female reproduction, possibly through its effects on calcium homeostasis, cyclic sex steroid hormone fluctuations, or neurotransmitter function. We have assessed the ef...

Medical and Biotech [MESH] Definitions

Painful menstruation.

An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout.

A cyclooxygenase inhibiting, non-steroidal anti-inflammatory agent (NSAID) that is well established in treating rheumatoid arthritis and osteoarthritis and used for musculoskeletal disorders, dysmenorrhea, and postoperative pain. Its long half-life enables it to be administered once daily.

More From BioPortfolio on "Efficacy and Safety Study of NPC-01 to Treat Dysmenorrhea"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial